Denver, CO, United States of America

Pradyot Nandi

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: University of Colorado, Bristol-Myers Squibb Compnay, Soligenix, Inc.. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pradyot Nandi. Retrieved from https://idiyas.com/inventor/pradyot-nandi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Pradyot Nandi

Introduction

Pradyot Nandi is an accomplished inventor based in Princeton, NJ. He is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. Although he has not yet registered any patents, his contributions to the field of innovation are noteworthy.

Latest Patents

As of now, Pradyot Nandi holds no patents. However, his work in the biopharmaceutical sector indicates a strong potential for future innovations.

Career Highlights

Pradyot has built a solid career at Bristol-Myers Squibb Company. His role involves collaborating with various teams to develop new therapeutic solutions. His expertise in the field is recognized by his peers, and he is known for his dedication to advancing medical science.

Collaborations

Pradyot Nandi works closely with his coworker, Pavel Strop. Together, they contribute to various projects aimed at improving healthcare outcomes.

Conclusion

Pradyot Nandi is a promising inventor in the biopharmaceutical industry, and his future endeavors may lead to significant innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…